Larson Financial Group LLC Clearside Biomedical, Inc. Transaction History
Larson Financial Group LLC
- $2.12 Billion
- Q1 2025
A detailed history of Larson Financial Group LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 1,000 shares of CLSD stock, worth $880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$880% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLSD
# of Institutions
52Shares Held
11.6MCall Options Held
24KPut Options Held
12.1K-
Vanguard Group Inc Valley Forge, PA2.81MShares$2.47 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$1.93 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.93MShares$1.7 Million0.03% of portfolio
-
Black Rock Inc. New York, NY798KShares$702,3600.0% of portfolio
-
Geode Capital Management, LLC Boston, MA764KShares$672,3710.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $53M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...